Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.78M Sell
7,151
-550
-7% -$131K 1.25% 25
2020
Q4
$1.77M Buy
7,701
+150
+2% +$34.6K 1.22% 25
2020
Q3
$1.92M Hold
7,551
1.4% 23
2020
Q2
$1.78M Sell
7,551
-50
-0.7% -$11.4K 1.33% 24
2020
Q1
$1.54M Buy
7,601
+150
+2% +$32.8K 1.34% 24
2019
Q4
$1.8M Hold
7,451
1.29% 29
2019
Q3
$1.44M Buy
7,451
+30
+0.4% +$5.76K 1.05% 33
2019
Q2
$1.32M Buy
7,421
+1,181
+19% +$211K 0.96% 35
2019
Q1
$1.19M Buy
6,240
+50
+0.8% +$9.55K 0.9% 38
2018
Q4
$1.21M Hold
6,190
1% 36
2018
Q3
$1.16M Buy
6,190
+430
+7% +$84.7K 0.94% 36
2018
Q2
$1.06M Buy
5,760
+80
+1% +$14.2K 0.85% 39
2018
Q1
$968K Buy
5,680
+520
+10% +$95.5K 0.8% 40
2017
Q4
$897K Hold
5,160
0.71% 42
2017
Q3
$962K Hold
5,160
0.79% 43
2017
Q2
$889K Buy
5,160
+50
+1% +$8.13K 0.74% 44
2017
Q1
$838K Buy
5,110
+810
+19% +$135K 0.69% 45
2016
Q4
$629K Buy
4,300
+400
+10% +$60.2K 0.55% 45
2016
Q3
$651K Buy
3,900
+552
+16% +$93.3K 0.57% 45
2016
Q2
$509K Buy
+3,348
New +$521K 0.41% 53

Other funds holding AMGN

Investment Counsel's AMGN Position: Q1 2021 in Review

Investment Counsel reduced its Amgen (AMGN) stake by 7.1% in Q1 2021, selling an estimated $131K and leaving 7,151 shares worth $1.78M. The position accounts for 1.25% of the portfolio, ranked #25.

Investment Counsel first reported a position in AMGN in Q2 2016 and has held it in 20 quarters since. The position peaked at $1.92M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Investment Counsel held 7,151 shares of Amgen worth $1.78M as of Q1 2021.
  • Investment Counsel sold 550 Amgen shares in Q1 2021, an estimated $131K.
  • Amgen made up 1.25% of Investment Counsel's portfolio in Q1 2021, its #25 holding.
  • Investment Counsel first reported a position in Amgen in Q2 2016 and has held it in 20 quarters since.
  • Investment Counsel's Amgen position peaked at $1.92M in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.